ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,998Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 1155

$286K Total Retail Price of All Prescriptions

Rank: 253 out of 1155

501 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 7,180 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 374 344 1 2
LISINOPRIL 325 300 2 1
FUROSEMIDE 223 217 3 8
HYDROCODONE-ACETAMINOPHEN 217 182 S3 4 4
METFORMIN HCL 195 174 5 7
HYDROCHLOROTHIAZIDE 185 181 6 9
GABAPENTIN 177 166 7 15
METOPROLOL SUCCINATE 172 169 8 17
LOVASTATIN 169 142 9 13
ATENOLOL 169 159 9 10
AMLODIPINE BESYLATE 167 164 11 6
OMEPRAZOLE 165 140 12 5
WARFARIN SODIUM 162 151 13 11
SIMVASTATIN 162 161 13 3
ALLOPURINOL 144 144 15 29
ZOLPIDEM TARTRATE 141 125 16 21
LOSARTAN POTASSIUM 133 127 17 18
ATORVASTATIN CALCIUM 130 123 18 12
TAMSULOSIN HCL 128 125 19 27
TRAZODONE HCL 128 115 19 22
FLUOXETINE HCL 113 71 21 30
POTASSIUM CHLORIDE 98 98 22 16
PROPRANOLOL HCL 93 93 23 97
PREDNISONE 92 75 24 40
PROAIR HFA 85 76 25 31
ALENDRONATE SODIUM 82 70 26 25
SERTRALINE HCL 79 72 27 24
AMITRIPTYLINE HCL 76 60 R 28 42
DIGOXIN 74 70 29 54
CITALOPRAM HBR 65 52 30 19
METOPROLOL TARTRATE 64 59 31 14
MORPHINE SULFATE ER 64 42 S2 31 36
ENALAPRIL MALEATE 62 62 33 66
FLUTICASONE PROPIONATE 61 60 34 37
GLYBURIDE 60 60 R 35 75
LEVOXYL 59 59 36 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 57 36 26
CRESTOR 55 55 38 34
PREMARIN 53 53 R 39 110
METHENAMINE HIPPURATE 53 44 39 266
ROPINIROLE HCL 51 28 41 94
DONEPEZIL HCL 50 50 42 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.